StockData
Emmaus Life Sciences, Inc. logo

Emmaus Life Sciences, Inc. (EMMA) stock

EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.05−0.01 (-14.38%)

Close on Oct 19, 2026Market cap $6.03MP/E –Yield –

Emmaus Life Sciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Emmaus Life Sciences's price to book ratio was 7.1× on Apr 30, 2019, against 11.9× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Apr 30, 20197.1×+2.9
2018Dec 31, 20184.2×−15.1
2017Dec 29, 201719.3×–

More Emmaus Life Sciences figures

See a number that looks wrong?